Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  September 20, 2023
Global Regulatory Updates
Global Regulatory Update for September 2023

AUSTRALIA AICIS Extends Temporary Recordkeeping Provisions For NICNAS Introducers To April 1, 2024: On September 13, 2023, the Australian Industrial...

  September 20, 2023
News & Events
Career Opportunity: Regulatory Scientist/Quality Assurance Specialist

The Acta Group, LLC (Acta®) and affiliated law firm Bergeson & Campbell, P.C. (B&C®) are seeking a Regulatory Scientist/Quality Assurance...

  September 12, 2023
Lynn L. Bergeson, “Expanding PFAS liability in the US,” Financier Worldwide, July 2023.

Few words inspire the panic that ‘polyfluoroalkyl substance (PFAS)’ does. Companies producing, processing, distributing and using (whether...

  September 7, 2023
NSTC’s Sustainable Chemistry Strategy Team Releases Sustainable Chemistry Report

On August 3, 2023, the Joint Subcommittee on Environment, Innovation, and Public Health Sustainable Chemistry Strategy Team (Sustainable Chemistry ST)...

  August 24, 2023
UN Publishes GHS Rev 10

On July 27, 2023, the United Nations (UN) published an electronic version of the tenth revision (Rev 10) of the Globally Harmonized System...

  August 17, 2023
Health Canada Begins Consultation on Proposed New Requirements for Consumer Chemical Products under the CCPSA

Health Canada has begun a consultation on a proposal to introduce new requirements for consumer chemical products under the Canada Consumer...

Seminars & Webinars

  December 5, 2023
Seminars & Webinars
TOP TSCA TOPICS: Cumulative Risk, NAMs, Risk Evaluations, CBI, and More!, May 17, 2023 11:00 a.m. – 12:00 p.m. (EDT), via webinar

During this one-hour webinar, Anna B. Lowit, Ph.D., Senior Science Advisor, the U.S. Environmental Protection Agency (EPA) Office of Pollution...

  December 5, 2023
Seminars & Webinars
Preparing A PFAS Gameplan in the U.S., UK, and EU, July 11, 2023, via webinar

The Acta Group (Acta®) and EPPA’s July 11, 2023, webinar, “Preparing a PFAS Game Plan in the U.S., the UK, and the EU,” is now available...

  December 5, 2023
Seminars & Webinars
Product Stewardship Practices for Effective Supply Chain Interaction, August 1, 2023 via webinar

This webinar explored current and proposed international regulations and restrictions in developed and emerging legislation and provided examples...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms
Map of Bergeson & Campbell locations

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Hexagons image collage

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.